The global life sciences industry sits at the center of modern healthcare innovation. Every new biologic drug, vaccine, gene therapy, diagnostic test, and laboratory discovery depends on a network of companies supplying instruments, reagents, chemicals, filtration systems, and manufacturing technologies.
Among these industry leaders, Merck KGaA’s Life Science division (MilliporeSigma in North America) competes directly with Thermo Fisher Scientific, Cytiva, Sartorius, Avantor, Agilent Technologies, and Revvity. While all these companies play important roles, they differ significantly in revenue, market reach, scientific reputation, and influence across research and biopharmaceutical manufacturing.
The Industry Giant: Thermo Fisher Scientific
When discussing global life sciences leadership, Thermo Fisher Scientific is often considered the benchmark.
The company generated approximately USD 42.9 billion in revenue in 2025, making it the largest life sciences tools company in the world. Its products support pharmaceutical companies, biotechnology firms, academic institutions, government laboratories, hospitals, and diagnostic centers.
Thermo Fisher’s strength comes from its broad portfolio covering laboratory consumables, analytical instruments, diagnostics, clinical research services, bioprocessing equipment, and pharmaceutical manufacturing support.
Because of its extensive global footprint and presence in nearly every laboratory category, Thermo Fisher is often viewed as the most visible brand in the industry.
Merck/MilliporeSigma: A Brand Scientists Trust
While Thermo Fisher leads in size, Merck’s Life Science business is frequently recognized for scientific quality and reliability.
Merck KGaA reported approximately €21.2 billion in total company revenue during 2025, with its Life Science division contributing around €9.3 billion. The business serves customers in more than 60 countries and supports thousands of pharmaceutical, biotechnology, and academic research organizations.
The company is particularly strong in:
- Laboratory reagents and chemicals
- Research materials
- Filtration technologies
- Cell culture media
- Bioprocessing solutions
- Gene and cell therapy services
Many researchers continue to associate the Sigma-Aldrich brand with premium laboratory products and dependable quality. As a result, Merck often ranks among the most respected scientific brands globally.
Cytiva and Sartorius: Powering the Biologics Revolution
The rapid growth of biologics, cell therapies, gene therapies, and GLP-1 medicines has increased demand for advanced bioprocessing technologies.
This trend has transformed Cytiva and Sartorius into some of the most strategically important companies in life sciences.
Sartorius generated approximately €3.54 billion in revenue during 2025, with bioprocess solutions accounting for the majority of sales. Its filtration systems, bioreactors, and cell culture technologies are widely used in commercial biologics manufacturing.
Cytiva, operating within Danaher’s Life Sciences segment, contributes to a business unit that generated roughly USD 25 billion in revenue during 2025. Cytiva has become a leading supplier of single-use technologies, chromatography systems, bioreactors, and cell and gene therapy manufacturing platforms.
Many modern biologics facilities rely heavily on Cytiva and Sartorius technologies, making both companies critical players in global drug production.
Avantor: The Global Supply Chain Leader
Avantor may receive less attention than Thermo Fisher or Merck, but it remains one of the world’s largest suppliers of laboratory products and services.
The company generated approximately USD 6.8 billion in revenue during 2025. Through its VWR distribution network, Avantor serves pharmaceutical companies, research institutions, hospitals, and industrial laboratories worldwide.
Its extensive supply chain capabilities make it an essential partner for laboratory operations and procurement teams.
Agilent and Revvity: Specialized Scientific Leaders
Agilent Technologies generated approximately USD 6.7 billion in revenue during fiscal 2025 and remains one of the most respected brands in analytical sciences.
Its chromatography systems, mass spectrometers, spectroscopy instruments, and laboratory software are widely used in pharmaceutical development, environmental testing, food safety, and academic research.
Revvity generated approximately USD 2.8 billion in revenue during 2025. The company focuses on diagnostics, genomics, newborn screening, reproductive health, imaging technologies, and drug discovery solutions.
Although smaller than Thermo Fisher and Merck, Revvity maintains a strong reputation in specialized healthcare and diagnostics markets.
Global Life Sciences Market Comparison
| Company | 2025 Revenue | Global Presence | Brand Perception | Core Strength |
|---|---|---|---|---|
| Thermo Fisher Scientific | USD 42.9 Billion | Very High | Industry Giant | End-to-end life sciences solutions |
| Merck Life Science (MilliporeSigma) | EUR 9.3 Billion* | Very High | Trusted Scientific Brand | Reagents, chemicals, filtration, bioprocessing |
| Cytiva (Danaher Life Sciences Segment) | Part of USD 25 Billion+ Segment | High | Bioprocessing Leader | Biologics manufacturing |
| Sartorius | EUR 3.54 Billion | High | Premium Bioprocess Brand | Cell culture and filtration |
| Avantor | USD 6.8 Billion | High | Reliable Supplier | Laboratory distribution and consumables |
| Agilent Technologies | USD 6.7 Billion | High | Analytical Science Expert | Chromatography and diagnostics |
| Revvity | USD 2.8 Billion | Medium-High | Diagnostics Specialist | Genomics and screening |
*Life Science division revenue.
Who Wins on Market Presence and Brand Perception?
If revenue and overall market presence are considered, Thermo Fisher remains the clear industry leader due to its unmatched scale and broad portfolio.
However, when scientific reputation and customer trust are evaluated, Merck/MilliporeSigma stands among the strongest brands in the world. The Sigma-Aldrich legacy, combined with Merck’s expertise in chemicals, reagents, filtration, and bioprocessing, gives the company a unique position within research laboratories and pharmaceutical manufacturing facilities.
Cytiva and Sartorius dominate many areas of biologics production, while Agilent leads analytical sciences. Avantor provides the infrastructure that keeps laboratories running, and Revvity continues to strengthen its position in diagnostics and genomics.
Together, these companies form the backbone of the global life sciences industry, supporting everything from early-stage laboratory research to large-scale commercial drug manufacturing.
Access our exclusive, data-rich dashboard dedicated to the life science industry – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Towards Healthcare Research and Consulting is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium